Clinical Scorecard: MRI May Improve Prostate Cancer Monitoring

At a Glance

Key Highlights

• MRI should emphasize change over time rather than single time points.
• Volume assessment may better reflect tumor burden than maximum diameter.
• The PRECISE system provides a standardized framework for reporting changes.
• Longitudinal assessment improves clinical interpretation of MRI findings.
• Changes in tumor volume and growth rates are critical for monitoring progression.

Guideline-Based Recommendations

Diagnosis

• Use MRI for monitoring structural changes in prostate cancer.

Management

• Integrate MRI findings with clinical factors like PSA levels and patient characteristics.

Monitoring & Follow-up

• Focus on measurable changes over time, such as tumor volume and growth rates.

Risks

• Consider patient age, comorbidities, and prior histologic findings when determining the need for repeat biopsy or treatment.

Patient & Prescribing Data

Patients on active surveillance for prostate cancer.

MRI should be used serially to assess changes in tumor characteristics.

Clinical Best Practices

• Review prior MRI studies together for comprehensive assessment.
• Measure lesion volume consistently at each time point.
• Combine qualitative and quantitative data in reporting.

References

• Radiology